Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0025362 (
mental retardation
)
15,878
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ZNF630
is a member of the primate-specific Xp11 zinc finger gene cluster that consists of six closely related genes, of which ZNF41, ZNF81, and ZNF674 have been shown to be involved in
mental retardation
. This suggests that mutations of
ZNF630
might influence cognitive function. Here, we detected 12
ZNF630
deletions in a total of 1,562 male patients with
mental retardation
from Brazil, USA, Australia, and Europe. The breakpoints were analyzed in 10 families, and in all cases they were located within two segmental duplications that share more than 99% sequence identity, indicating that the deletions resulted from non-allelic homologous recombination. In 2,121 healthy male controls, 10
ZNF630
deletions were identified. In total, there was a 1.6-fold higher frequency of this deletion in males with
mental retardation
as compared to controls, but this increase was not statistically significant (P-value = 0.174). Conversely, a 1.9-fold lower frequency of
ZNF630
duplications was observed in patients, which was not significant either (P-value = 0.163). These data do not show that
ZNF630
deletions or duplications are associated with
mental retardation
.
...
PMID:Recurrent deletion of ZNF630 at Xp11.23 is not associated with mental retardation. 2018 89